Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A fossil record of zidovudine resistance in transmitted isolates of HIV-1.

× No keyword cloud information.

26 in total

1. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors: D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal: Nat Med Date: 1999-05 Impact factor: 53.440

2. Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group.

Authors: A Imrie; A Carr; C Duncombe; R Finlayson; J Vizzard; M Law; J Kaldor; R Penny; D A Cooper
Journal: J Infect Dis Date: 1996-07 Impact factor: 5.226

3. Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.

Authors: S Yerly; A Rakik; S K De Loes; B Hirschel; D Descamps; F Brun-Vézinet; L Perrin
Journal: J Virol Date: 1998-05 Impact factor: 5.103

4. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.

Authors: J Goudsmit; A De Ronde; D D Ho; A S Perelson
Journal: J Virol Date: 1996-08 Impact factor: 5.103

5. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.

Authors: P R Harrigan; S Bloor; B A Larder
Journal: J Virol Date: 1998-05 Impact factor: 5.103

6. Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

Authors: D R Kuritzkes; J B Quinn; S L Benoit; D L Shugarts; A Griffin; M Bakhtiari; D Poticha; J J Eron; M A Fallon; M Rubin
Journal: AIDS Date: 1996-08 Impact factor: 4.177

7. Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.

Authors: D Arion; N Kaushik; S McCormick; G Borkow; M A Parniak
Journal: Biochemistry Date: 1998-11-10 Impact factor: 3.162

8. Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group.

Authors: R T D'Aquila; V A Johnson; S L Welles; A J Japour; D R Kuritzkes; V DeGruttola; P S Reichelderfer; R W Coombs; C S Crumpacker; J O Kahn; D D Richman
Journal: Ann Intern Med Date: 1995-03-15 Impact factor: 25.391

9. Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism.

Authors: P R Meyer; S E Matsuura; A G So; W A Scott
Journal: Proc Natl Acad Sci U S A Date: 1998-11-10 Impact factor: 11.205

10. Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group.

Authors: A J Japour; S Welles; R T D'Aquila; V A Johnson; D D Richman; R W Coombs; P S Reichelderfer; J O Kahn; C S Crumpacker; D R Kuritzkes
Journal: J Infect Dis Date: 1995-05 Impact factor: 5.226

8 in total

Review 1. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Authors: Nila Bhana; Douglas Ormrod; Caroline M Perry; David P Figgitt
Journal: Paediatr Drugs Date: 2002 Impact factor: 3.022

2. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.

Authors: J Gerardo García-Lerma; Hamish MacInnes; Diane Bennett; Hillard Weinstock; Walid Heneine
Journal: J Virol Date: 2004-07 Impact factor: 5.103

3. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.

Authors: Zabrina L Brumme; Chanson J Brumme; Jonathan Carlson; Hendrik Streeck; Mina John; Quentin Eichbaum; Brian L Block; Brett Baker; Carl Kadie; Martin Markowitz; Heiko Jessen; Anthony D Kelleher; Eric Rosenberg; John Kaldor; Yuko Yuki; Mary Carrington; Todd M Allen; Simon Mallal; Marcus Altfeld; David Heckerman; Bruce D Walker
Journal: J Virol Date: 2008-07-09 Impact factor: 5.103

4. The multiplicity of infection of a plant virus varies during colonization of its eukaryotic host.

Authors: Pablo González-Jara; Aurora Fraile; Tomás Canto; Fernando García-Arenal
Journal: J Virol Date: 2009-05-27 Impact factor: 5.103

5. Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations.

Authors: Yumi Mitsuya; Vici Varghese; Chunlin Wang; Tommy F Liu; Susan P Holmes; Prerana Jayakumar; Baback Gharizadeh; Mostafa Ronaghi; Daniel Klein; W Jeffrey Fessel; Robert W Shafer
Journal: J Virol Date: 2008-08-20 Impact factor: 5.103

6. Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.

Authors: Thuy Le; Jennifer Chiarella; Birgitte B Simen; Bozena Hanczaruk; Michael Egholm; Marie L Landry; Kevin Dieckhaus; Marc I Rosen; Michael J Kozal
Journal: PLoS One Date: 2009-06-29 Impact factor: 3.240

Review 7. Efficacy and Tolerability of Tenofovir Disoproxil Fumarate Based Regimen as Compared to Zidovudine Based Regimens: A Systematic Review and Meta-Analysis.

Authors: Tegene Legese Dadi; Adane Teshome Kefale; Teshale Ayele Mega; Muktar Sano Kedir; Habtamu Acho Addo; Tessema Tsehay Biru
Journal: AIDS Res Treat Date: 2017-05-30

Review 8. Treatment Outcome and Adverse Events of Tenofovir Disoproxil Fumarate Based Regimens as Compared to Zidovudine Based Regimens Among People Living with HIV/AIDS: A Systematic Review and Meta-Analysis of Observational Studies.

Authors: Adane Teshome Kefale; Tegene Legese Dadi; Tessema Tsehay Biru; Teshale Ayele Mega
Journal: Open AIDS J Date: 2018-05-31

8 in total